Bradbury Daniel 的 Form 4 申報
Castle Biosciences Inc（CSTL），2022/2/24 申報
- 申報編號
- 0001447362-22-000028
- 申報時間
- 2022/2/24
- 交易日
- 2022/2/22-2/23
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $69.3 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Bradbury DanielCIK 0001236397 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/2/22 | Common Stock | S賣出處分 | −3,852 | $38.65F2 | −$148,879.8 | 204,512 | 間接 | |
| 2022/2/22 | Common Stock | S賣出處分 | −2,500 | $39.09F4 | −$97,725 | 110,037 | 間接 | |
| 2022/2/22 | Common Stock | S賣出處分 | −2,500 | $39.50F6 | −$98,750 | 110,062 | 間接 | |
| 2022/2/23 | Common Stock | S賣出處分 | −3,852 | $38.97F8 | −$150,112.44 | 200,660 | 間接 | |
| 2022/2/23 | Common Stock | S賣出處分 | −2,500 | $39.18F9 | −$97,950 | 107,537 | 間接 | |
| 2022/2/23 | Common Stock | S賣出處分 | −2,500 | $39.71F10 | −$99,275 | 107,562 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $38.170 to $39.000, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $39.000 to $39.180, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $39.180 to $39.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F8
This transaction was executed in multiple trades at prices ranging from $38.885 to $39.050, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F9
This transaction was executed in multiple trades at prices ranging from $39.050 to $39.370, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F10
This transaction was executed in multiple trades at prices ranging from $39.375 to $40.020, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。